Dr. Nao Takada — Principal Attorney
Dr. Nao Takada combines deep scientific training with extensive legal experience to represent clients in complex patent litigation, pharmaceutical and biotech disputes, and cross-border product liability cases. Admitted in New York, Texas, and before the USPTO, Dr. Takada bridges law and science to deliver strategic legal solutions for global life sciences and technology companies.
Experience
- Principal, Takada Legal P.C. (2017–Present)
- Attorney, Paul Hastings LLP (2016–2017)
- Associate, Gibson Dunn & Crutcher LLP (2015–2016)
- Associate, WilmerHale (2015)
- Associate, Paul Hastings LLP (2012–2015)
- Postdoctoral Researcher, Columbia University (2010–2011)
Affiliations
- American Bar Association
Education & Qualifications
- McWilliams School of Biomedical Informatics at UTHealth Houston – Biomedical Informatics Certification (In Progress)
- Registered Patent Attorney, USPTO (2014)
- Admitted to New York State Bar (2012)
- LL.M., New York University School of Law (2012)
- Ph.D., Genetics & Development, Columbia University (2010)
- BA in Biology, Amherst College (2004, Phi Beta Kappa; Uchimura Scholarship)
- LLB, University of Tokyo (2002)
Representative Litigation Matters
- Lead counsel for major Japanese pharmaceutical companies in multiple U.S. ANDA litigations against generic manufacturers concerning blockbuster diabetes therapies, with matters extending to Canada, India, and Latin America.
- Biologic patent infringement litigation for Gilead Sciences.
- IPR proceedings involving Japanese and U.S. pharmaceutical companies.
- Biotech patent litigation including Gevo Inc. v. Butamax Advanced Biofuels.